Jarushka Naidoo
Enriched profileAcademic Professor of Medical Oncology, RCSI Department of Medicine · RCSI University of Medicine and Health Sciences (Dublin)
Jarushka Naidoo is Academic Professor of Medical Oncology, RCSI Department of Medicine at RCSI University of Medicine and Health Sciences (Dublin). ClinicalTrials.gov lists 5 registered studies with this person as an investigator.
Data verified 9 Nov 2026
Overview
Updated 9 Nov 2026
Jarushka Naidoo, MB BCH BAO, is Academic Professor of Medical Oncology, RCSI Department of Medicine at RCSI University of Medicine and Health Sciences (Dublin). It also documents an investigator role on 5 registered clinical trials, industry payments reported by 9 companies.
- Top research focus: Lung Cancer (NSCLC/SCLC)
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 9 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 9 Nov 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- The Lung Health Check Pilot
Sponsor: Royal College of Surgeons, Ireland
- Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status
Sponsor: ETOP IBCSG Partners Foundation
Industry payments
Updated 9 Nov 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20251 payment
- Genentech USA, Inc.Program year20251 payment
- Regeneron Pharmaceuticals, Inc.Program year20242 payments
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Phenothiazine100%Prochlorperazine Maleate100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Background & recognition
Updated 9 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rcsi.com ↗
- Master of Health Science (Clinical Investigation)
Bloomberg School of Public Health, Johns Hopkins University
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rcsi.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.ie ↗
Secondary affiliations
appointments beyond the home institution- Adjunct Assistant Professor of Oncology
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University (date not stated)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →accc-cancer.org ↗
Media & interviews
press, podcasts and appearances- Irish Cancer Society patient-voice feature
'Prof Jarushka Naidoo: I won't stop using my voice to spread the message that lung cancer and clinical trials...'
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.ie ↗ - Podcast episode featuring Dr Jarushka Naidoo
described as an immunotherapy toxicity expert (Johns Hopkins)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →listen.hubhopper.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Ignacio Wistuba, MD
Moffitt Cancer Center
Pasi Janne, MD, PhD
Dana-Farber Cancer Institute
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Enriqueta Felip, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)